AGREEMENT WITH RESPECT TO SCHEDULE 13DAgreement With Respect to Schedule 13d • May 8th, 2006 • Bay City Capital LLC • In vitro & in vivo diagnostic substances
Each of Bay City Capital LLC, Bay City Capital Management IV LLC, Bay City Capital Fund IV, L.P. and Bay City Capital Fund IV Co-Investment Fund, L.P. hereby express its agreement that the attached Schedule 13D (and any amendments thereto) relating to the common stock of NeoRx Corporation is filed on behalf of each of them.
